Skip to content
VERO Biotech logo — Transforming The Delivery of Inhaled Nitric Oxide

VERO Biotech

Transforming The Delivery of Inhaled Nitric Oxide

Founded 2006 United States Atlanta, United States 213 employees Venture round Total: $234.64M Biotechnology, Health Care +1

General Information

Company Name VERO Biotech
Founded Year 2006
Location United States Atlanta, United States
Founders / Decision Makers
Team member
Employees 213
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with VERO Biotech. To contact VERO Biotech, visit vero-biotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VERO Biotech compare?

A PDF of VERO Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VERO Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About VERO Biotech

VERO Biotech is an emerging biotechnology company founded in 2006, with a focus on designing, developing, and commercializing next-generation inhaled nitric oxide (NO) delivery systems. The company's slogan "Transforming The Delivery of Inhaled Nitric Oxide" encapsulates its mission to address unmet medical needs of patients with cardiopulmonary conditions. Based in the United States, Vero Biotech is committed to enhancing the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is necessary.

With its recent $30.00M Venture Round investment on 11 January 2023 from Petrichor Healthcare, Vero Biotech has attracted the attention of investors in the Biotechnology, Health Care, and Pharmaceutical industries. The company's dedication to exceeding customer expectations in terms of safety, efficacy, and growth, by focusing on the science, development, and commercialization of their innovations, signals a promising future for those considering investment opportunities in the biotechnology sector.

Business keywords: inhalation therapy, nitric oxide, cardiopulmonary conditions, drug delivery systems, acute care, pulmonary diseases, cardiac diseases, innovation, clinical solutions, pharmaceuticals

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $30.00M 1
Petrichor Healthcare Capital Management
11 Jan 2023
Series E $100.00M 1
MVM Life Science Partners
21 Dec 2021
Debt Financing $50.00M 1
Runway Growth Capital
20 Jan 2021
Venture Round $29.94M -
29 Sep 2017
Private Equity Round $14.57M -
03 Oct 2013
Venture Round $7.99M -
30 Dec 2011
Venture Round $2.14M -
14 Sep 2009

VERO Biotech Alternatives & Competitors

View All Alternatives
VERO Biotech vs

developing innovative drugs and drug delivery systems that improve the quality of life of oncology p...

Series A
7 employees
Biopharma, Biotechnology
VERO Biotech vs

Pioneering Respiratory Patient Care

Series A
4 employees
Biotechnology, Life Sciences
VERO Biotech vs

Developing novel treatments of inflammatory diseases and cancer

Debt Financing
3 employees
Biopharma, Biotechnology

FAQ About VERO Biotech

Transforming The Delivery of Inhaled Nitric Oxide
VERO Biotech was founded in 2006.
VERO Biotech is headquartered in Atlanta, United States.
VERO Biotech operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on inhalation therapy, nitric oxide, cardiopulmonary conditions and drug delivery systems.
VERO Biotech has approximately 213 employees.
VERO Biotech has completed 7 funding rounds, raising a total of $234.64M. The latest funding stage is Venture round.
Top alternatives and competitors to VERO Biotech include OnQuality Pharmaceuticals Ltd., Nob Hill Therapeutics, Cantex Pharmaceuticals, Inc., Airway Therapeutics, Microbion Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VERO Biotech and OnQuality Pharmaceuticals Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VERO Biotech, https://bouncewatch.com/company/vero-biotech, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout